Keeps Biopharma

킵스파마 · 256940

Health Care Pharmaceuticals · KOSDAQ

Small-cap

Market cap US$94.7M (₩130.7B)

Overview

Keeps Biopharma is a pharmaceutical and biotechnology company listed on KOSDAQ, South Korea's tech-focused small-cap exchange.

It operates in the health-care sector, developing and supplying pharmaceutical or biopharmaceutical products, though the available filing text does not detail specific product lines or end-markets. The company is currently loss-making while its revenue has been growing year over year.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$123.3M

▲ +33.4% YoY

Operating profit · FY2025

US$1.1M

▼ −74.7% YoY

Net income · FY2025

−US$7.5M

Turned to loss

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2023	FY2024	FY2025
Revenue	US$66.8M(₩92.1B)	US$92.5M(₩127.6B)	US$123.3M(₩170.1B)
Operating profit	US$2.2M(₩3.1B)	US$4.5M(₩6.2B)	US$1.1M(₩1.6B)
Net income	US$2.5M(₩3.5B)	US$1.2M(₩1.6B)	−US$7.5M(−₩10.4B)

Revenue

FY2023US$66.8M
FY2024US$92.5M
FY2025US$123.3M

Operating profit

FY2023US$2.2M
FY2024US$4.5M
FY2025US$1.1M

Net income

FY2023US$2.5M
FY2024US$1.2M
FY2025−US$7.5M

Key ratios (FY2025)

ROE

-12.7%

Debt/Eq

187.0%

Op. margin

0.9%

Net margin

-6.1%

Rev. YoY

▲ +33.4%

Price charts coming soon

Interactive price history isn't here yet. Would you use it?